{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T07:50:11Z","timestamp":1761292211208},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,2,1]]},"DOI":"10.1093\/eurheartj\/ehi038","type":"journal-article","created":{"date-parts":[[2004,12,20]],"date-time":"2004-12-20T20:14:07Z","timestamp":1103573647000},"page":"250-256","source":"Crossref","is-referenced-by-count":13,"title":["Risk assessment in patients with unstable angina\/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide"],"prefix":"10.1093","volume":"26","author":[{"given":"Rudolf","family":"Jarai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelly","family":"Iordanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Jarai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"Raffetseder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Woloszczuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariann","family":"Gy\u00f6ngy\u00f6si","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Geyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johann","family":"Wojta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt","family":"Huber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2004,12,20]]},"reference":[{"key":"key\n\t\t\t\t20171012005806_EHI038C1","doi-asserted-by":"crossref","unstructured":"Tsutamoto T, Wada A, Maeda K et\u00a0al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation1997;96:509\u2013516.","DOI":"10.1161\/01.CIR.96.2.509"},{"key":"key\n\t\t\t\t20171012005806_EHI038C2","doi-asserted-by":"crossref","unstructured":"Tsutamoto T, Wada A, Maeda K et\u00a0al. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1. Eur Heart J1999;20:1799\u20131807.","DOI":"10.1053\/euhj.1999.1746"},{"key":"key\n\t\t\t\t20171012005806_EHI038C3","doi-asserted-by":"crossref","unstructured":"de Lemos JA, Morrow DA, Bentley JH et\u00a0al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med2001;345:1014\u20131021.","DOI":"10.1056\/NEJMoa011053"},{"key":"key\n\t\t\t\t20171012005806_EHI038C4","doi-asserted-by":"crossref","unstructured":"Arakawa N, Nakamura M, Aoki H et\u00a0al. Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction. J Am Coll Cardiol1996;27:1656\u20131661.","DOI":"10.1016\/0735-1097(96)00067-8"},{"key":"key\n\t\t\t\t20171012005806_EHI038C5","doi-asserted-by":"crossref","unstructured":"Richards AM, Nicholls MG, Yandle TG et\u00a0al. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. The Christchurch Cardioendocrine Research Group. Heart1999;81:114\u2013120.","DOI":"10.1136\/hrt.81.2.114"},{"key":"key\n\t\t\t\t20171012005806_EHI038C6","doi-asserted-by":"crossref","unstructured":"Richards AM, Nicholls MG, Yandle TG et\u00a0al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation1998;97:1921\u20131929.","DOI":"10.1161\/01.CIR.97.19.1921"},{"key":"key\n\t\t\t\t20171012005806_EHI038C7","doi-asserted-by":"crossref","unstructured":"Omland T, Aakvaag A, Bonarjee VVS et\u00a0al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction: comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation1996;93:1963\u20131969.","DOI":"10.1161\/01.CIR.93.11.1963"},{"key":"key\n\t\t\t\t20171012005806_EHI038C8","doi-asserted-by":"crossref","unstructured":"McDonagh TA, Robb SD, Murdoch DR et\u00a0al. Biochemical detection of left-ventricular systolic dysfunction. Lancet1998;351:9\u201313.","DOI":"10.1016\/S0140-6736(97)03034-1"},{"key":"key\n\t\t\t\t20171012005806_EHI038C9","doi-asserted-by":"crossref","unstructured":"Omland T, de Lemos JA, Morrow DA et\u00a0al. Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes. Am J Cardiol2002;89:463\u2013465.","DOI":"10.1016\/S0002-9149(01)02271-8"},{"key":"key\n\t\t\t\t20171012005806_EHI038C10","doi-asserted-by":"crossref","unstructured":"Morrow DA, Lemos JAd, Sabatine MS et\u00a0al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina\/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. J Am Coll Cardiol2003;41:1264\u20131272.","DOI":"10.1016\/S0735-1097(03)00168-2"},{"key":"key\n\t\t\t\t20171012005806_EHI038C11","doi-asserted-by":"crossref","unstructured":"James S, Lindahl B, Siegbahn A et\u00a0al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease. Circulation2003;108:275\u2013281.","DOI":"10.1161\/01.CIR.0000079170.10579.DC"},{"key":"key\n\t\t\t\t20171012005806_EHI038C12","doi-asserted-by":"crossref","unstructured":"Sabatine MS, Morrow DA, de Lemos JA et\u00a0al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation2002;105:1760\u20131763.","DOI":"10.1161\/01.CIR.0000015464.18023.0A"},{"key":"key\n\t\t\t\t20171012005806_EHI038C13","doi-asserted-by":"crossref","unstructured":"Hall C, Cannon CP, Forman S et\u00a0al. Prognostic value of N-terminal proatrial natriuretic factor plasma levels measured within the first 12 hours after myocardial infarction. J Am Coll Cardiol1995; 26:1452\u20131456.","DOI":"10.1016\/0735-1097(95)00342-8"},{"key":"key\n\t\t\t\t20171012005806_EHI038C14","doi-asserted-by":"crossref","unstructured":"Hall C, Rouleau JL, Moye L et\u00a0al. N-terminal proatrial natriuretic factor an independent predictor of long-term prognosis after myocardial infarction. Circulation1994;89:1934\u20131942.","DOI":"10.1161\/01.CIR.89.5.1934"},{"key":"key\n\t\t\t\t20171012005806_EHI038C15","doi-asserted-by":"crossref","unstructured":"Dickstein K, Larsen AI, Bonarjee VVS et\u00a0al. Plasma proatrial natriuretic factor is predictive of clinical status in patients with congestive heart failure. Am J Cardiol1995;76:679\u2013683.","DOI":"10.1016\/S0002-9149(99)80196-9"},{"key":"key\n\t\t\t\t20171012005806_EHI038C16","doi-asserted-by":"crossref","unstructured":"Lerman A, Gibbons RJ, Rodeheffer R et\u00a0al. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet1993;341:1105\u20131109.","DOI":"10.1016\/0140-6736(93)93125-K"},{"key":"key\n\t\t\t\t20171012005806_EHI038C17","doi-asserted-by":"crossref","unstructured":"Jernberg T, Stridsberg M, Lindahl B. Usefulness of plasma N-terminal proatrial natriuretic petptide (proanp) as an early predictor of outcome in unstable angina pectoris or non-ST-elevation acute myocardial infarction. Am J Cardiol2002;89:64\u201366.","DOI":"10.1016\/S0002-9149(01)02166-X"},{"key":"key\n\t\t\t\t20171012005806_EHI038C18","doi-asserted-by":"crossref","unstructured":"Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med1998;339:321\u2013328.","DOI":"10.1056\/NEJM199807303390507"},{"key":"key\n\t\t\t\t20171012005806_EHI038C19","doi-asserted-by":"crossref","unstructured":"Marumoto K, Hamada M, Hiwada K. Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris. Clin Sci (Lond)1995;88:551\u2013556.","DOI":"10.1042\/cs0880551"},{"key":"key\n\t\t\t\t20171012005806_EHI038C20","doi-asserted-by":"crossref","unstructured":"Klinge R, Joergensen B, Thaulow E et\u00a0al. N-terminal proatrial natriuretic peptide in angina pectoris: impact of revascularization by angioplasty. Int J Cardiol1999;68:1\u20138.","DOI":"10.1016\/S0167-5273(98)00342-8"},{"key":"key\n\t\t\t\t20171012005806_EHI038C21","doi-asserted-by":"crossref","unstructured":"Kyriakides Z, Markianos M, Michalis L et\u00a0al. Brain natriuretic peptide increases acutely and much more prominently than atrial natriuretic peptide during coronary angioplasty. Clin Cardiol2000;23:285\u2013288.","DOI":"10.1002\/clc.4960230412"},{"key":"key\n\t\t\t\t20171012005806_EHI038C22","doi-asserted-by":"crossref","unstructured":"Tateishi J, Masutani M, Ohyanagi M et\u00a0al. Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty. Clin Cardiol2000;23:776\u2013780.","DOI":"10.1002\/clc.4960231016"},{"key":"key\n\t\t\t\t20171012005806_EHI038C23","doi-asserted-by":"crossref","unstructured":"Davidson NC, Naas AA, Hanson JK et\u00a0al. Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction. Am J Cardiol1996;77:828\u2013831.","DOI":"10.1016\/S0002-9149(97)89176-X"},{"key":"key\n\t\t\t\t20171012005806_EHI038C24","doi-asserted-by":"crossref","unstructured":"Nakagawa O, Ogawa Y, Itoh H et\u00a0al. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy: evidence for brain natriuretic peptide as an emergency cardiac hormone against ventricular overload. J Clin Invest1995;96:1280\u20131287.","DOI":"10.1172\/JCI118162"},{"key":"key\n\t\t\t\t20171012005806_EHI038C25","doi-asserted-by":"crossref","unstructured":"Tosteson T, Buzas J, Demidenko E et\u00a0al. Power and sample size calculations for generalized models with covariate measurement error. Stat Med2003;22:1069\u20131082.","DOI":"10.1002\/sim.1388"},{"key":"key\n\t\t\t\t20171012005806_EHI038C26","doi-asserted-by":"crossref","unstructured":"Cohen J. A power primer. Psychol Bull1992;112:155\u2013159.","DOI":"10.1037\/0033-2909.112.1.155"},{"key":"key\n\t\t\t\t20171012005806_EHI038C27","unstructured":"Jernberg T, Lagerqvist B, Stridsberg M et\u00a0al. N-terminal pro brain natriuretic peptide identifies patients with unstable coronary diseases who benefit from an early invasive strategy. Circulation2002;106:2439."},{"key":"key\n\t\t\t\t20171012005806_EHI038C28","doi-asserted-by":"crossref","unstructured":"Omland T, Persson A, Ng L et\u00a0al. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation2002;106:2913\u20132918.","DOI":"10.1161\/01.CIR.0000041661.63285.AE"},{"key":"key\n\t\t\t\t20171012005806_EHI038C29","doi-asserted-by":"crossref","unstructured":"Jarai R, Jarai R, Iordanova N et\u00a0al. Prediction of 2-year survival and composite endpoints using the TIMI-7 risk score extended by N-terminal pro-brain natriuretic peptide levels. J Am Coll Cardiol2003;41(Suppl. A): 367A.","DOI":"10.1016\/S0735-1097(03)82160-5"},{"key":"key\n\t\t\t\t20171012005806_EHI038C30","doi-asserted-by":"crossref","unstructured":"Ellmers LJ, Knowles JW, Kim HS et\u00a0al. Ventricular expression of natriuretic peptides in Npr1(\u2212\/\u2212) mice with cardiac hypertrophy and fibrosis. Am J Physiol Heart Circ Physiol2002;283:H707\u2013H714.","DOI":"10.1152\/ajpheart.00677.2001"},{"key":"key\n\t\t\t\t20171012005806_EHI038C31","doi-asserted-by":"crossref","unstructured":"Ogawa Y, Tamura N, Chusho H et\u00a0al. Brain natriuretic peptide appears to act locally as an antifibrotic factor in the heart. Can J Physiol Pharmacol2001;79:723\u2013729.","DOI":"10.1139\/y01-052"},{"key":"key\n\t\t\t\t20171012005806_EHI038C32","doi-asserted-by":"crossref","unstructured":"Tse MY, Watson JD, Sarda IR et\u00a0al. Expression of B-type natriuretic peptide in atrial natriuretic peptide gene disrupted mice. Mol Cell Biochem2001;219:99\u2013105.","DOI":"10.1023\/A:1011087513774"},{"key":"key\n\t\t\t\t20171012005806_EHI038C33","doi-asserted-by":"crossref","unstructured":"Sumida H, Yasue H, Yoshimura M et\u00a0al. Comparison of secretion pattern between A-type and B-type natriuretic peptides in patients with old myocardial infarction. J Am Coll Cardiol1995;25:1105\u20131110.","DOI":"10.1016\/0735-1097(94)00525-U"},{"key":"key\n\t\t\t\t20171012005806_EHI038C34","doi-asserted-by":"crossref","unstructured":"Yasue H, Yoshimura M, Sumida H et\u00a0al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation1994;90:195\u2013203.","DOI":"10.1161\/01.CIR.90.1.195"},{"key":"key\n\t\t\t\t20171012005806_EHI038C35","doi-asserted-by":"crossref","unstructured":"Hama N, Itoh H, Shirakami G et\u00a0al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation1995;92:1558\u20131564.","DOI":"10.1161\/01.CIR.92.6.1558"},{"key":"key\n\t\t\t\t20171012005806_EHI038C36","doi-asserted-by":"crossref","unstructured":"Horio T, Shimada K, Kohno M et\u00a0al. Serial changes in atrial and brain natriuretic peptides in patients with acute myocardial infarction treated with early coronary angioplasty. Am Heart J1993;126:293\u2013299.","DOI":"10.1016\/0002-8703(93)91042-D"},{"key":"key\n\t\t\t\t20171012005806_EHI038C37","doi-asserted-by":"crossref","unstructured":"Maeda K, Tsutamoto T, Wada A et\u00a0al. Insufficient secretion of atrial natriuretic peptide at acute phase of myocardial infarction. J Appl Physiol2000;89:458\u2013464.","DOI":"10.1152\/jappl.2000.89.2.458"},{"key":"key\n\t\t\t\t20171012005806_EHI038C38","doi-asserted-by":"crossref","unstructured":"Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology1983;148:839\u2013843.","DOI":"10.1148\/radiology.148.3.6878708"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/26\/3\/250\/6063399\/ehi038.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T19:29:30Z","timestamp":1546457370000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/eurheartj\/article\/26\/3\/250\/487162\/Risk-assessment-in-patients-with-unstable"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12,20]]},"references-count":38,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2004,12,20]]},"published-print":{"date-parts":[[2005,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehi038","relation":{},"ISSN":["1522-9645","0195-668X"],"issn-type":[{"value":"1522-9645","type":"electronic"},{"value":"0195-668X","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,2]]},"published":{"date-parts":[[2004,12,20]]}}}